A surgical suture is a medical device to close a surgical opening and stitch a congenital wound. It is used to repair internal organs after surgery as well as skin, blood vessels, and all other types of human body tissues. Sutures have the major property of being non-absorbable or absorbable, with varying properties (such as tensile strength and knot security) based on the surgical method and requirement.

In 2021, the market for surgical sutures was worth USD 4.04 billion, and by 2030, it will be worth USD 6.97 billion, growing at a 6.23% CAGR during the forecast period. 

The increasing number of surgical procedures is responsible for the surgical suture market's growth. This market is growing due to the favorable reimbursement status for several surgical procedures and the development of better sutures. However, the availability of alternate wound care management treatments and the increased desire for minimally invasive procedures will restrain the market's expansion.

Market Dynamics

Drivers

The market is accelerated by the rising desire for minimally invasive surgeries, the rising number of surgical procedures, and the growing availability of surgical sutures. 

The demand for minimally invasive surgery has grown over time due to its benefits over traditional open surgery, including smaller and fewer scars, less discomfort, shorter hospital stays and recovery times, lower costs, and overall superior results. 

Additionally, the demand for surgical sutures has grown due to the rising number of surgeries globally. In 2021, hospitals in the United Kingdom carried out an average of 7.9 million procedures (inclusive category), 5.1 million procedures (intermediate category), and 1.5 million procedures (restrictive category), driving the need for surgical sutures in this region. 

Restraints

The expansion of the market may be limited to some extent by the availability of alternative wound care management options and the rising demand for minimally invasive procedures.

Opportunity 

In order to provide their citizens with access to proper healthcare facilities, several governments in emerging economies are attempting to ensure that health insurance is available to more people in their respective countries. These elements increase the likelihood that the suture market will expand globally in such economies.

Market Segmentation

By Product

In 2021, the absorbable segment led the entire market with a share of 55.0%, as it can temporarily sustain wounds until they heal and can endure typical stress. Additionally, absorbable sutures are in high demand due to their capacity for natural degradation. As a result, major market participants are spending money on R&D projects, which will likely contribute to the future expansion of the absorbable industry.

By Application

In 2021, the other segment held the majority of the market, with a share of more than 35.0%. The cardiovascular surgery segment was the second-largest market in 2021 in terms of revenue share. The significant share of this segment is due to the high prevalence of cardiac disorders, the availability of enough specialists in the field, favorable reimbursement conditions, and improvements in diagnostics. Due to this, significantly more cardiac operations are being performed, which will raise demand for surgical sutures over the projection period.

By End-User

The hospital segment commanded the market in 2020 with a revenue share of 74.7%. The largest share of this segment is due to the rising elderly population, the favorable payment policies for hospital care, and the rising number of new hospitals, particularly in developing countries.

Regional Analysis

In 2021, North America held the largest market share of approximately 40%. The largest market share is due to the presence of local and major players, the favorable reimbursement environment, the high cost of sutures relative to other regions, expanding government initiatives, and the developed healthcare infrastructure. The significant revenue share of North America is also due to technological improvements and strong domestic wealth.

Asia Pacific region will expand at a rapid rate. This is attributable to the expanding senior population base, which is more prone to undergo surgery, and an increase in government investment in healthcare infrastructure to satisfy the region's unmet needs. China, India, and Japan are the major market in this region. Another significant driver propelling the market in this area toward exponential growth is the rise of medical tourism in nations like India, Singapore, and Malaysia.

Key Players 

· Boston Scientific Corporation,

· B. Braun Melsungen AG,

· Ethicon Inc. (Johnson & Johnson)

· Medtronic plc,

· Teleflex Incorporated,

· InternacionalFarmacéutica S.A. De C.V.,

· Smith & Nephew,

· CONMED Corporation,

· DemeTech Corporation,

· EndoEvolution, LLC,

· Peters Surgical,

· Sutures India,

· Surgical Specialties Corporation,

· Mellon Medical B.V.

In 2021, the market for surgical sutures was worth USD 4.04 billion, and by 2030, it will be worth USD 6.97 billion, growing at a 6.23% CAGR during the forecast period. A major factor boosting market expansion for surgical sutures is the rise in surgical operations worldwide. Additionally, a key factor anticipated to propel market growth for surgical sutures globally over the forecast period is the growing emphasis on developing technologically advanced suture designs. 

Related Reports:

Apheresis Market Report - The global apheresis market will witness a robust CAGR of 7.78%, valued at $1.79 billion in 2021, expected to appreciate and reach $3.87 billion by 2030, confirms Strategic Market Research. Apheresis is defined as a medical procedure that involves the purification of blood or the separation of distinct blood components.